Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Rowing and cycling: a new exercise combo to fight diabetes inflammation?

NCT ID NCT07769840

Disease control Sponsor: The 95th Hospital of Putian，Putian, Fujian, China Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This trial tests whether different combinations of rowing and cycling exercise can reduce inflammation and improve blood sugar control in people newly diagnosed with type 2 diabetes. Participants, aged 18-60 and not yet on medication, will be assigned to one of five exercise programs or a control group. The study measures inflammatory markers, body composition, and blood sugar fluctuations over a short period. The goal is to find the most effective exercise routine for early diabetes management.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Behavioral intervention: exercise regimens combining rowing and cycling
What this could lead to
If successful, this could point toward a personalized exercise prescription to help manage early type 2 diabetes and reduce inflammation.
What could go wrong
This is a short-term (7-day) trial, so long-term benefits are uncertain. Results may not apply to all diabetes patients, and exercise carries a small risk of injury.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age between 18-60 years, no gender limited; 2. Meeting the WHO 1999 diagnostic criteria for T2DM, with a diagnosis time ≤12 months; 3. Not having received hypoglycemic drug treatment (or only lifestyle intervention, and stopped medication ≥4 weeks before enrollment); 4. Fasting blood glucose 7.0-13.9 mmol/L, glycated hemoglobin (HbA1c) 6.5%-10.0%; 5. No regular exercise in the past 3 months (less than 2 times per week of moderate or higher intensity exercise, each \<30 minutes); 6. Voluntarily signing the informed consent form. Exclusion Criteria: 1. Type 1 diabetes, gestational diabetes, or other special types of diabetes; 2. Severe cardiovascular or cerebrovascular diseases (NYHA heart function ≥III, recent myocardial infarction or unstable angina); 3. Uncontrolled hypertension (resting systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥100 mmHg); 4. Severe liver or kidney dysfunction (ALT/AST ≥3 times the upper limit of normal, or eGFR\<60 mL/min/1.73m²); 5. Severe diabetic complications (such as proliferative retinopathy, severe neuropathy, diabetic foot); 6. Pregnant or breastfeeding women; 7. Mental illness or cognitive impairment that prevents compliance with the study; 8. Stress events such as infection, trauma, or surgery in the past month; 9. Participation in other interventional clinical studies; 10. Musculoskeletal diseases of the upper or lower limbs that affect rowing machine or bicycle exercise.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Ethics Committee of Putian 95 Hospital

    Putian, Fujian, 351100, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.